Adjuvant chemotherapy for resected intrahepatic cholangiocarcinoma confers no survival advantage Meeting Abstract
| Authors: | Sharib, J.; Liu, A.; McIntyre, S. M. H.; Rhodin, K. E.; Kemeny, N. E.; Cercek, A.; Harding, J. J.; Abou-Alfa, G. K.; Soares, K.; Wei, A. C. C.; Drebin, J. A.; Kingham, T. P.; D'Angelica, M. I.; Uronis, H. E.; Strickler, J. H.; Morse, M.; Zani, S.; Allen, P. J.; Jarnagin, W. R.; Lidsky, M. |
| Abstract Title: | Adjuvant chemotherapy for resected intrahepatic cholangiocarcinoma confers no survival advantage |
| Meeting Title: | 2023 ASCO Gastrointestinal Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 41 |
| Issue: | 4 Suppl. |
| Meeting Dates: | 2023 Jan 19-21 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2023-02-01 |
| Language: | English |
| DOI: | 10.1200/JCO.2023.41.4_suppl.560 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cinahl |
| DOI/URL: | |
| Notes: | Meeting Abstract: 560 -- Accession Number: 161485023 -- Entry Date: In Process -- Revision Date: 20230127 -- Publication Type: Article -- Supplement Title: 2/1/2023 Supplement 1 -- Journal Subset: Biomedical; Editorial Board Reviewed; Expert Peer Reviewed; Peer Reviewed; USA -- NLM UID: 8309333. -- Source: Cinahl |
Altmetric
Citation Impact
BMJ Impact Analytics
